Cargando…
Aldehyde dehydrogenase is used by cancer cells for energy metabolism
We found that non-small-cell lung cancer (NSCLC) cells express high levels of multiple aldehyde dehydrogenase (ALDH) isoforms via an informatics analysis of metabolic enzymes in NSCLC and immunohistochemical staining of NSCLC clinical tumor samples. Using a multiple reaction-monitoring mass spectrom...
Autores principales: | Kang, Joon Hee, Lee, Seon-Hyeong, Hong, Dongwan, Lee, Jae-Seon, Ahn, Hee-Sung, Ahn, Ju-Hyun, Seong, Tae Wha, Lee, Chang-Hun, Jang, Hyonchol, Hong, Kyeong Man, Lee, Cheolju, Lee, Jae-Ho, Kim, Soo-Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133370/ https://www.ncbi.nlm.nih.gov/pubmed/27885254 http://dx.doi.org/10.1038/emm.2016.103 |
Ejemplares similares
-
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion
por: Kang, Joon Hee, et al.
Publicado: (2016) -
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
por: Lee, Jae-Seon, et al.
Publicado: (2019) -
Reply to Krupenko et al., Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382”
por: Lee, Seon-Hyeong, et al.
Publicado: (2021) -
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
por: Lee, Jae-Seon, et al.
Publicado: (2016) -
The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer
por: Lee, Seon-Hyeong, et al.
Publicado: (2020)